AdvanSix (NYSE: ASIX) reported Q3 EPS of $0.88, $0.22 better than the analyst estimate of $0.66. Revenue for the quarter came in at $398.18 million versus the consensus estimate of $357.65 million.

Outlook

Ammonium sulfate order book sold through 4Q24 amid continued strong sulfur nutrition demand
Expect balanced to tight global acetone supply and demand conditions
Expect North American nylon industry spreads to modestly improve amid stable end market demand
Expect Capital Expenditures to now be $135 to $140 million in 2024, reflecting refined execution timing to address critical enterprise risk mitigation and growth projects including our SUSTAIN (Sustainable U.S. Sulfate to Accelerate Increased Nutrition) program
As a result of additional required maintenance and a delayed ramp to full operating rates at our Hopewell site following our planned plant turnaround, we expect an incremental approximately $17 million unfavorable impact to pre-tax income in 4Q24, inclusive of $10 million related to fixed cost absorption and higher maintenance expense, and $7 million of lost sales; no impact on 3Q24 results

For earnings history and earnings-related data on AdvanSix (ASIX) click here.